Being able to detect early on whether a cancer therapy is working proffers obvious benefits for therapy-outcomes whilst influencing the course of treatment and improving the quality of life for … Continue Reading Novel ‘reporter’ nanoparticle reveals cancer treatment effectiveness in real-time.
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. Most often, prostate cancer spreads to the bones and also to the liver … Continue Reading Nanoparticles hitchhike on whiteblood cells to kill tumour cells in bloodstream.
It has been shown that patterns of poor nutritional intake may exacerbate the elevated morbidity experienced by cancer survivors. While most cancer patients in the United States are motivated to … Continue Reading Large-scale study investigates the diet quality of cancer survivors.
Since their discovery in the 1950s, transfer RNAs (tRNAs) have been best known for their role in helping the cell make proteins from messenger RNA templates. However, recent studies have … Continue Reading Researchers discover new species of tRNA responsible for sex-biased cancer proliferation.
A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current … Continue Reading Study finds $1 test using gold nanoparticles outperforms PSA screen for prostate cancer.
The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new … Continue Reading Study maps why different sets of genes are activated by androgen receptor in prostate cancer cells.
Researchers from the Vanderbilt University, the University of Toronto and Chronix Biomedical have demonstrated a method for detecting ‘cell-free’ tumour DNA in the bloodstream. The team believe that the technique … Continue Reading Researchers develop epigenetic ‘cell-free’ DNA blood test for prostate cancer.
UT Southwestern Medical Center researchers have demonstrated that whole-genome sequencing can be used to identify patients’ risk for hereditary cancer, which can potentially lead to improvements in cancer prevention, diagnosis, … Continue Reading Researchers confirm whole-genome sequencing can identify cancer-related mutations and risk.
A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart … Continue Reading Prostate cancer medications linked to increased heart-related death risk.